CClinicalTrials.gg
Sign In
RecruitingNCT06757023Updated Jan 3, 2025

A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment

An observational study in Postoperative Complications, Postoperative Pain and Acupuncture, sponsored by The First Affiliated Hospital of Xiamen University. Recruiting at 2 sites in China. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-01-03.

Sponsored by The First Affiliated Hospital of Xiamen University · Observational

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
110
Ages
18 Years to 55 Years
Sex
All
01

Study summary

To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery

02

Conditions studied

  • Postoperative Complications
  • Postoperative Pain
  • Acupuncture
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's planned enrollment of 110 is below the median of 254 across 519 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

The First Affiliated Hospital of Xiamen University is the lead sponsor of 115 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing breast cancer surgery with general anesthesia in the hospital

Inclusion criteria

  1. Patients undergoing breast cancer surgery with general anesthesia in the hospital;
  2. American Society of Anesthesiologists (ASA) classification I-II;
  3. Women aged 18-55 years;
  4. No history of chronic insomnia;
  5. Individuals who have not taken sedative-hypnotic drugs within the past month.

Exclusion criteria

Exclusion Criteria:

  1. Those who do not meet the aforementioned inclusion criteria;
  2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);
  3. A history of sleep disorders and psychiatric history;
  4. Inability to receive thumb-tack needle treatment.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients undergoing breast cancer surgery with general anesthesia in the hospital
06

What researchers measure

Primary outcomes

  1. Pittsburgh sleep quality index(PSQI)

    Total scores range from 0 to 21, with higher scores indicating worse sleep quality.

    Time frame: 1 day or 2 days before anesthesia exposure and 1, 3, and 7 days after anesthesia exposure.

Secondary outcomes

  1. Later Recovery evaluated by QoR-40 questionnaire

    The maximum total score is 200, with higher scores indicating better recovery quality

    Time frame: QoR-40 score on the third day after surgery

07

Study locations

2 of 2 sites recruiting
  • First Affiliated Hospital of Xiamen University
    Xiamen, Fujian 361000, China
    Recruiting
  • First Affiliated Hospital of Xiamen University
    Xiamen, Fujian 361000, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06757023
Lead sponsor
The First Affiliated Hospital of Xiamen University
Responsible party
Yang Bin (Principal Investigator, Fujian Medical University) — Principal investigator
First posted
Jan 3, 2025
Start date
Nov 13, 2024
Primary completion
Oct 13, 2026 (estimated)
Completion
Nov 13, 2026 (estimated)
Last update
Jan 3, 2025

Study contacts

Bin Yang doctor
Contact
yangbin4332@outlook.com
1385998603

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Postoperative Complications→

Other studies from this sponsor

The First Affiliated Hospital of Xiamen University

Start the discussion